A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Indolent Non-Hodgkin's Lymphoma
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Vorinostat (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 10 Jun 2016 Status changed from active, no longer recruiting to completed.
- 08 Dec 2015 Planned End Date changed from 1 Mar 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 08 Dec 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.